NCT06551142 - A Study of GSK5764227 in Participants With Advanced Solid Tumors | Biotech Hunter

Enrollment

316

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

September 24, 2026

Study Completion Date

May 19, 2027

Conditions

Neoplasms

Interventions

BIOLOGICAL

GSK5764227

GSK5764227 will be administered

DRUG

Cisplatin

Cisplatin will be administered

DRUG

Carboplatin

Carboplatin will be administered

BIOLOGICAL

Atezolizumab

Atezolizumab will be administered

BIOLOGICAL

Pembrolizumab

Pembrolizumab will be administered

BIOLOGICAL

Durvalumab

Durvalumab will be administered

BIOLOGICAL

Cetuximab

Cetuximab will be administered

BIOLOGICAL

Bevacizumab

Bevacizumab will be administered

Trial Locations (42)

500

RECRUITING

GSK Investigational Site, Changhua

704

RECRUITING

GSK Investigational Site, Tainan City

10408

RECRUITING

GSK Investigational Site, Gyeonggi-do

11217

RECRUITING

GSK Investigational Site, Taipei

28034

RECRUITING

GSK Investigational Site, Madrid

28040

RECRUITING

GSK Investigational Site, Madrid

28041

RECRUITING

GSK Investigational Site, Madrid

29010

RECRUITING

GSK Investigational Site, Málaga

29572

RECRUITING

GSK Investigational Site, Myrtle Beach

33076

RECRUITING

GSK Investigational Site, Bordeaux

37203

RECRUITING

GSK Investigational Site, Nashville

40447

RECRUITING

GSK Investigational Site, Taichung

48201

RECRUITING

GSK Investigational Site, Detroit

75230

RECRUITING

GSK Investigational Site, Dallas

78229

RECRUITING

GSK Investigational Site, San Antonio

80218

RECRUITING

GSK Investigational Site, Denver

83301

RECRUITING

GSK Investigational Site, Kaohsiung City

84119

RECRUITING

GSK Investigational Site, West Valley City

94063

RECRUITING

GSK Investigational Site, Stanford

94805

RECRUITING

GSK Investigational Site, Villejuif

06511

RECRUITING

GSK Investigational Site, New Haven

02114

RECRUITING

GSK Investigational Site, Boston

08903

RECRUITING

GSK Investigational Site, New Brunswick

S2002

COMPLETED

GSK Investigational Site, Rosario

R8500ACE

RECRUITING

GSK Investigational Site, Viedma

K1H 8L6

RECRUITING

GSK Investigational Site, Ottawa

M5G 1X6

RECRUITING

GSK Investigational Site, Toronto

H4A 3J1

RECRUITING

GSK Investigational Site, Montreal

J1H 5N4

RECRUITING

GSK Investigational Site, Sherbrooke

464-8681

RECRUITING

GSK Investigational Site, Aichi

277-8577

RECRUITING

GSK Investigational Site, Chiba

411-8777

RECRUITING

GSK Investigational Site, Shizuoka

104-0045

RECRUITING

GSK Investigational Site, Tokyo

135-8550

RECRUITING

GSK Investigational Site, Tokyo

Unknown

RECRUITING

GSK Investigational Site, Panama City

RECRUITING

GSK Investigational Site, Panama City

03080

RECRUITING

GSK Investigational Site, Seoul

03722

RECRUITING

GSK Investigational Site, Seoul

135-710

RECRUITING

GSK Investigational Site, Seoul

08036

RECRUITING

GSK Investigational Site, Barcelona

EH4 2XU

RECRUITING

GSK Investigational Site, Edinburgh

G12 0YN

RECRUITING

GSK Investigational Site, Glasgow